Economic burden of non-alcoholic steatohepatitis with significant fibrosis in Thailand

Economic burden of non-alcoholic steatohepatitis with significant fibrosis in Thailand

Abstract Background Non-alcoholic steatohepatitis (NASH) has been recognised as a significant form of chronic liver disease and a common cause of cirrhosis and hepatocellular carcinoma, resulting in a considerable financial burden on healthcare resources. Currently, there is no information regarding...

Full description

Bibliographic Details
Main Authors: Pochamana Phisalprapa, Ratthanon Prasitwarachot, Chayanis Kositamongkol, Pranaidej Hengswat, Weerachai Srivanichakorn, Chaiwat Washirasaksiri, Sombat Treeprasertsuk, Phunchai Charatcharoenwitthaya, Nathorn Chaiyakunapruk
Format: Article
Language:English
Published: BMC 2021-03-01
Series:BMC Gastroenterology
Subjects:
Non-alcoholic steatohepatitis
NASH
Significant fibrosis
Economic burden
Cost of illness
Prevalence
Online Access:https://doi.org/10.1186/s12876-021-01720-w

Internet

https://doi.org/10.1186/s12876-021-01720-w

Similar Items